MediThinQ, a Korean startup specialising in extended reality (XR) wearable displays for surgery, is making waves as the first Asian startup to globally launch XR surgical displays.

The company has successfully secured significant deals with industry giants, including Medtronic USA and Japan, marking a substantial milestone in its international expansion efforts.

In tandem, MediThinQ has secured a multimillion-dollar investment from JLK Technology, a Singapore-headquartered medical devices manufacturer, who will also help accelerate MediThinQ's mass production as its appointed manufacturer.

MediThinQ's XR solutions present critical information directly in from of the surgeon's eyes, eliminating the need to divert attention to screens. The first of its kind in revolutionising how medical information is accessed in live surgeries, they are backed by best-in-class image fidelity, latency, reliability, and equipment compatibility.

MediThinQ's flagship products, Scopeye and MetaSCOPE, already hold regulatory approvals in key markets including the US (FDA), Europe (CE), Japan (PMDA), and Korea (KFDA). Looking ahead, MediThinQ is gearing up to launch its next product line targeting the burgeoning Chinese market. It is also exploring applications beyond the medical space, including a collaboration with one of the largest conglomerates in Korea. MediThinQ is currently raising its Series B fund while exploring IPO options in Singapore, Hong Kong, and North America.